首页 > 市场调查报告书 > 医疗设备

灌注系统市场规模、份额和成长分析（按年龄、应用、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1900212

灌注系统市场规模、份额和成长分析（按年龄、应用、最终用户和地区划分）—产业预测（2026-2033 年）

Perfusion System Market Size, Share, and Growth Analysis, By Age Group (Adults, Pediatrics), By Application (Cardiopulmonary Perfusion System, Cell Perfusion System), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球灌注系统市场规模将达到 13.4 亿美元，到 2025 年将达到 13.9 亿美元，到 2033 年将达到 18.9 亿美元，预测期（2026-2033 年）的复合年增长率为 3.9%。

全球灌注系统市场对医疗保健和生物医学研究至关重要，尤其是在器官移植和细胞研究领域。这些专用设备能够将富含氧气和营养物质的液体可控地输送到体外的生物组织和器官，因此对于在运输和实验室中维持器官活性至关重要。器官移植需求的不断增长正在推动市场成长，因为灌注系统对于保存和评估捐赠器官至关重要，最终有助于提高移植成功率。灌注技术的进步，例如常温灌注，延长了器官保存时间，并提高了器官活性评估的准确性。此外，这些系统在药物和生物技术研究中也发挥关键作用，它们能够促进细胞和组织培养，帮助研究疾病机制并开发新型治疗方法。对先进技术和研发倡议的持续投入预计将推动市场持续成长。

全球灌注系统市场驱动因素

器官衰竭发病率的上升以及移植器官需求的不断增长，正显着推动全球体外循环灌注系统市场的发展。这些先进的系统对于保存和评估捐赠器官至关重要，有助于提高移植手术的整体成功率。随着医学界致力于改善移植患者的预后，对体外循环灌注技术的依赖性日益增强。这一趋势凸显了有效器官管理策略的重要性，并推动了体外循环灌注设备的创新和投资，以满足移植领域不断增长的需求。总而言之，这些因素正在塑造一个充满活力且不断扩张的市场格局。

限制全球灌注系统市场的因素

全球体外循环系统市场面临严峻的挑战，这主要归因于严格的监管要求，这些要求强制规定必须遵守严格的安全性和有效性标准。这些合规要求可能会阻碍创新步伐，并延缓新型体外循环技术的市场推广。由于企业努力遵守这些法规，核准流程往往漫长而复杂，这可能会阻碍企业及时获得先进的解决方案。进而，这会限制对高性能体外循环系统的需求，影响整体市场成长以及市场快速反应不断变化的医疗需求和技术进步的能力。

全球灌注系统市场趋势

全球灌注系统市场正经历显着成长，这主要得益于常温灌注技术的日益普及。这种创新方法能够在运输过程中将移植器官维持在生理温度下，彻底革新了器官保存和评估领域，从而提高了器官存活率和移植成功率。随着医疗专业人员和移植中心逐渐认识到延长器官保存时间和更精确评估器官功能的潜在益处，对先进灌注技术的需求也不断增长。此外，持续进行的旨在优化灌注液的研发工作也推动了这一趋势，进一步巩固了常温灌注在移植和重症监护领域的重要作用。

心肺灌注系统
- 氧合设备
- 体外循环机
- 灌注帮浦
- 套管
- 监控系统
- 其他的
- 动脉滤器
- 储存
- 资料管理系统
- 心臟麻痹药物输送系统
- 热交换器
- 配件
细胞灌注系统
- 生物反应器灌注系统
- 微流体灌注系统
- 重力/压力驱动灌注系统
- 小乳腺器官灌注系统
离体器官灌注系统
- 低温
- 正常体温
体外膜氧合（ECMO）
离体器官灌注系统

全球灌流系统市场规模（依最终用户划分），复合年增长率（2026-2033 年）

医院和门诊手术中心（ASC）
专科诊所
其他的

全球灌流系统市场规模，复合年增长率（2026-2033）

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

ICU Medical（United States）
B. Braun（Germany）
Delcath Systems（United States）
Fresenius Medical Care（Germany）
Terumo Corporation（Japan）
Medtronic（Ireland）
Getinge AB（Sweden）
LivaNova（United Kingdom）
Edwards Lifesciences（United States）
Nipro Corporation（Japan）
CytoSorbents Corporation（United States）
Spectrum Medical（United Kingdom）
Eurosets（Italy）
Biomedica（Austria）
Soma Technology（United States）

结论与建议

简介目录

Product Code: SQMIG35G2252

Global Perfusion System Market size was valued at USD 1.34 Billion in 2024 and is poised to grow from USD 1.39 Billion in 2025 to USD 1.89 Billion by 2033, growing at a CAGR of 3.9% during the forecast period (2026-2033).

The global perfusion system market is essential in medical and biomedical research, notably for organ transplantation and cellular studies. These specialized devices enable the controlled flow of oxygenated and nutrient-rich fluids through biological tissues or organs outside the body, crucial for maintaining organ viability during transport and laboratory experiments. The increasing demand for organ transplants drives market growth, as perfusion systems are vital for preserving and assessing donor organs, ultimately enhancing transplant success rates. Advances in perfusion technology, such as normothermic perfusion, allow for longer maintenance and better organ viability assessments. Additionally, these systems play a critical role in pharmaceutical and biotechnology research by facilitating cell and tissue culturing, thereby supporting disease mechanism studies and novel treatment developments. The market is poised for continued growth as investments in advanced technologies and research initiatives expand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Perfusion System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Perfusion System Market Segments Analysis

Global Perfusion System Market is segmented by Age Group, Application, End User and region. Based on Age Group, the market is segmented into Adults and Pediatrics. Based on Application, the market is segmented into Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System, Extracorporeal Membrane Oxygenation (ECMO) and Isolated Organ Perfusion Systems. Based on End User, the market is segmented into Hospitals & ASCs, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Perfusion System Market

The rising incidence of organ failure, coupled with a heightened demand for transplantable organs, significantly propels the Global Perfusion System market. These advanced systems are crucial for the preservation and evaluation of donor organs, thereby enhancing the overall success rates of transplantation procedures. As the healthcare sector focuses on improving outcomes for patients in need of transplants, the reliance on perfusion technologies becomes increasingly vital. This trend underscores the importance of effective organ management strategies, driving innovation and investment in perfusion devices to meet the growing needs within the transplant community. Overall, these factors contribute to a dynamic and expanding market landscape.

Restraints in the Global Perfusion System Market

The Global Perfusion System market faces significant challenges due to stringent regulatory requirements that necessitate adherence to rigorous standards for safety and efficacy. These compliance mandates can impede the pace of innovation and delay the introduction of new perfusion technologies into the market. As companies strive to meet these regulations, the often lengthy and complex approval processes can hinder timely access to advanced solutions. Consequently, the demand for enhanced perfusion systems may be stifled, affecting overall market growth and the ability to respond swiftly to evolving healthcare needs and technological advancements in the field.

Market Trends of the Global Perfusion System Market

The global market for perfusion systems is witnessing significant growth driven by the increasing adoption of normothermic perfusion techniques. This innovative approach, which maintains donor organs at physiological temperatures during transport, is revolutionizing organ preservation and assessment, leading to enhanced viability and improved transplant success rates. As healthcare professionals and transplant centers recognize the potential benefits of extended protection times and better evaluations of organ function, demand for advanced perfusion technology is on the rise. This trend is also fueled by ongoing research and development efforts aimed at optimizing perfusion solutions, further solidifying normothermic perfusion's role in transplantation and critical care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Perfusion System Market Size by Age Group & CAGR (2026-2033)

Market Overview
Adults
Pediatrics

Global Perfusion System Market Size by Application & CAGR (2026-2033)

Market Overview
Cardiopulmonary Perfusion System
- Oxygenators
- Heart-Lung Machine
- Perfusion Pumps
- Cannula
- Monitoring System
- Others
- Arterial Filters
- Reservoirs
- Data Management Systems
- Cardioplegia Delivery Systems
- Heat Exchangers
- Accessories
Cell Perfusion System
- Bioreactor Perfusion System
- Microfluidic Perfusion System
- Gravity/Pressure-driven Perfusion System
- Small Mammal Organ Perfusion System
Ex-Vivo Organ Perfusion System
- Hypothermic
- Normothermic
Extracorporeal Membrane Oxygenation (ECMO)
Isolated Organ Perfusion Systems

Global Perfusion System Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & ASCs
Specialty Clinics
Others

Global Perfusion System Market Size & CAGR (2026-2033)

North America (Age Group, Application, End User)
- US
- Canada
Europe (Age Group, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Age Group, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Age Group, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Age Group, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

ICU Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Delcath Systems (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CytoSorbents Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Spectrum Medical (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurosets (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomedica (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soma Technology (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments